Revenues soar in 1Q for Merge eFilm
PACS vendor Merge eFilm reported a first quarter net sales increase of 41% to $8.64 million compared with $6.12 million in the previous year's quarter ended March 31, 2003. Operating income was $2.14 million, an increase of 45% compared with $1.48
PACS vendor Merge eFilm reported a first quarter net sales increase of 41% to $8.64 million compared with $6.12 million in the previous year's quarter ended March 31, 2003. Operating income was $2.14 million, an increase of 45% compared with $1.48 million in the previous year's quarter. Net income was $1.35 million compared with $1.32 million in 1Q 2003. Financial and operational gains reflected increasing popularity of the company's Fusion RIS/PACS. The company closed 17 deals for its Fusion RIS, PACS, or RIS/PACS during the quarter, increasing the total number of Fusion customers to 143, representing more than 290 healthcare facilities. Company executives anticipate continuing positive market conditions, with full-year 2004 guidance of 30% to 35% revenue growth year over year to a range of $37.5 to $39.5 million.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
